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More than 15 years have elapsed since the discovery of the sarcoglycan complex 
(SGC) [1] and the characteristics of this original complex have been fairly studied in 
succeeding years later [2]. 
In details, sarcoglycan (SG) is a component of the larger dystrophin-associated 
glycoproteins complex (DAGC) called DGC also [1]. The DAGC is composed of at 
least ten proteins links laminin2 (merosin) of the extracellular matrix and actin, stabi-
lizing the cell membrane during muscle activity. Three subcomplex can be identified 
in the DAGC on the basis of different biochemical characteristic and localization: the 
sarcoplasmic subcomplex, made up of the dystrophin, dystrobrevin and syntrophin 
complex; the dystroglycan subcomplex, made up of a- and b-dystroglycan; the SGC, 
composed of six SG subunits (a, b, g, d, e and z-SG). SGC subcomplex is an independ-
ent complex that is not directly associated with dystrophin and it plays a key role in 
signalling functions maintaining sarcolemma viability in muscle fiber membrane. As 
mutations in any one of SG subunits cause autosomal recessive limb-girdle muscular 
dystrophy (LGMD), characterized by integrity of dystrophin, SGC can be considered 
as associated system of DAGC and for this, it seems to be functionally as important 
as dystrophin. 
Moreover, previous reports have demonstrated that SGs are localized in skeletal 
and cardiac muscle forming the costameres, also showing that these proteins are co-
localized with integrins in these regions in skeletal muscle in the region of the sar-
colemma over I or A bands on the basis of the fiber types, slow or fast respectively 
[3,4]. These results have reinforced the hypothesis of a functional connection between 
SGs and integrins through a bidirectional signalling [5] which seems to be impor-
tant to alleviate muscle diseases and to improve the survival of a severely dystrophic 
mouse model of Duchenne muscular dystrophy. For this, in our opinion the study of 
SGs implies also the consequent analysis of the integrins in many different tissues. 
Furthermore, it was demonstrated the presence of all SGs, and then of an exam-
eric arrangement of SGC, in smooth muscle fibers of many districts [6,7] emphasizing 
an important correlation between SGs and frequency of contraction force [7,8]. 
Whereas the expression of a and g-SG is restricted to striated muscle cells, the oth-
er SGs are widely expressed in various tissues as levels of b, d and e-SG were highest 
in lung, moderate in brain, heart, and low, but detectable in kidney and liver [9]. 
Then, since this complex is not considered as muscle-specific, previously we have 
analyzed the SGs in non-muscle tissues, as well as digestive, respiratory and urinary 
epithelial cells. Interestingly, our immunohistochemical results showed the presence 
of all SGs in all tested tissues. About this, recently, we analyzed SGC in biopsies 
obtained from human breast and prostate in normal and pathological conditions in 
order to study these proteins also in glandular epithelium. Our results showed, for 
the first time, that in normal conditions, staining pattern for all SGs has been detecta-
6ble and distributed in both epithelial and myoepithelial cells. Moreover, observations 
on samples of pathological tissues have shown that immunofluorescence for all SGs 
appears to be severely reduced in benign diseases, and almost absent in malignant 
syndromes. 
These results were confirmed also by data obtained on gingival epithelium in 
normal and pathological conditions. Particularly, our results on normal gingival epi-
thelium showed the presence of SGC in this tissue confirming that SGs are ubiqui-
tously distributed; in gingival epithelium, obtained from patients during inflamma-
tory processes, due to treatment with bisphosphonates, staining pattern for SGs was 
decreased.
Then, SGs could play a crucial role in oncogenesis since it is possible to hypoth-
esize that these diseases could be due to lack of SGs in epithelial cells; moreover, the 
invasivity of malignant syndromes could be provoke by homology of SGs sequences 
with that of cadherins, transmembrane glycoproteins that are essential for cell-cell 
adhesion [10].
Additionally, it is known that even in the central nervous system the DGC exists 
but differs in composition from the DGC core present in muscle for the presence of 
several isoforms of dystrophin and for the existence of a SGC which is made up only 
for ε- and ζ-SG. On this, in our previous study we have analyzed the SGs expres-
sion and localization in rat’s cerebral cortex and our results showed that all SGs are 
present with a staining pattern in relation to the cerebral cortex area observed. In par-
ticular we think that they could be associated with synapse sites such as inhibitory 
GABAA Rε and D5DR receptors. Furthermore, the same analysis carried out on the 
brain of the WAG/Rij rats, a model of absence epilepsy, confirmed this role for SGs.
On this basis, in order to understand the real function of SGs and integrins and 
their relationship with contraction forces, we studied these proteins in masseter mus-
cle which, as well known, is highly unusual compared with other muscles; in fact, in 
addition to normal slow and fast fibers, this muscle contains fibers types which are 
typical for developing or cardiac muscle. Many fibers are hybrid, and they are impor-
tant for the specific functional demands of masseter; these fibers probably increase 
the capacity of the masseter muscle to generate a large variety of motor tasks. 
First, to evaluate differences in muscles with different functions, we analyzed SGs 
and integrins in normal human masseter muscle compared with masseter muscle 
affected by unilateral right crossbite. Our results, in according to electromyographic 
evaluations, showed a decrease of SGs and integrins in crossbite side in respect to 
counterpart and to control subjects. Interestingly, in the crossbite side we observed 
an increase of b1D-integrin, an isoform detected in differentiating myofibers, playing 
a key role in muscle regeneration and appearing to have a minor role in mature skel-
etal muscle.
Moreover, to comprehend the different role playing by SGC and integrins and 
to individuate a phylogenetic diversity in the expression of these proteins, we stud-
ied these proteins also in non human species. Particularly, we obtained masseter 
muscle biopsies from chimpanzees and baboons, individuating different classes of 
dominance, high and low dominance, for baboons, and alpha and non-alpha male 
for chimpanzees. About chimpanzees, our results have shown a different quantita-
tive composition of integrins in alpha male in respect to non-alpha male hypothesiz-
ing a key role for integrins and SGs in the determination of contraction force. About 
7baboons, Our immunohistochemical results, confirmed also by Western Blotting 
analysis, show that, in high dominance subjects, stainings for SGs and integrins were 
normal; interestingly, in low dominance subjects, stainings for these proteins were 
normal, lower or absent in different fibers of the same microscopic field. Thus, pre-
liminary analysis on cell cultures of myoblasts and myotubes, at different days of dif-
ferentiation, immunolabelled with antibodies against SGs and integrins, have demon-
strated a similar behaviour, showing cells with an higher or lower staining for these 
proteins providing a first suggestion that integrins and SGs in masseter muscle play 
a key role regulating muscular functional activity and allowing the optimization of 
contractile forces of this muscle.
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